Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
about
Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance PredictionPharmacodynamics of antimicrobials against Mycoplasma mycoides mycoides small colony, the causative agent of contagious bovine pleuropneumoniaComparative pharmacokinetics of cefuroxime lysine after single intravenous, intraperitoneal, and intramuscular administration to rats.Efficacy of enrofloxacin in a mouse model of sepsis.The pharmacokinetics of enrofloxacin in adult African clawed frogs (Xenopus laevis).Pharmacokinetic study on pradofloxacin in the dog - comparison of serum analysis, ultrafiltration and tissue sampling after oral administrationRadiosynthesis and biological evaluation of a novel enoyl-ACP reductase inhibitor for Staphylococcus aureusIntegrated pharmacokinetics/pharmacodynamics parameters-based dosing guidelines of enrofloxacin in grass carp Ctenopharyngodon idella to minimize selection of drug resistancePharmacokinetics of cefovecin in cynomolgus macaques (Macaca fascicularis), olive baboons (Papio anubis), and rhesus macaques (Macaca mulatta)Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.Systemic and mammary gland disposition of enrofloxacin in healthy sheep following intramammary administrationEffect of probiotics on enrofloxacin disposition in gastrointestinal tract of poultry.Pharmacokinetics and bioavailability of doxycycline in ostriches (Struthio camelus) at two different dose ratesResponse of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.Fosfomycin: Uses and potentialities in veterinary medicinePharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes.Influence of systemic fluoroquinolone administration on the presence of Pasteurella multocida in the upper respiratory tract of clinically healthy calves.Integration of pharmacokinetic and pharmacodynamic indices of orbifloxacin in beagle dogs after a single intravenous and intramuscular administration.Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases.Effect of chronic lead intoxication on the distribution and elimination of amoxicillin in goats.Pharmacokinetics of amoxicillin trihydrate in male Asian elephants (Elephas maximus) following intramuscular administration.Pharmacokinetics of intravenous clindamycin phosphate in captive Bennett's wallabies (Macropus rufogriseus).Plasma and synovial fluid pharmacokinetics of cefquinome following the administration of multiple doses in horses.Pharmacokinetics of enrofloxacin after oral, intramuscular and bath administration in crucian carp (Carassius auratus gibelio).Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.Efficacy of a new recrystallized enrofloxacin hydrochloride-dihydrate against leptospirosis in a hamster model.Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin as a single injection for Pasteurellaceae respiratory infections in cattle using population pharmacokinetics and Monte Carlo simulations.Plasma, subcutaneous tissue and bone concentrations of ceftiofur sodium after regional limb perfusion in horses.Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves.Pharmacokinetics and bioavailability of flumequine in blunt snout bream (Megalobrama amblycephala) after intravascular and oral administrations.Pharmacokinetics of cefuroxime after intravenous, intramuscular, and subcutaneous administration to dogs.Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits.Pharmacokinetic-pharmacodynamic integration of enrofloxacin and its metabolite ciprofloxacin in buffalo calves.Chronokinetics of ceftazidime after intramuscular administration to dogs.Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.Comparative activity of pradofloxacin and marbofloxacin against coagulase-positive staphylococci in a pharmacokinetic-pharmacodynamic model based on canine pharmacokinetics.Pharmacokinetics and residue depletion of erythromycin in gilthead sea bream Sparus aurata L. after oral administration.
P2860
Q26753831-B762BA76-E525-43D0-9651-DC161652386CQ28482671-063E9973-A940-4317-98FD-29D198BE438AQ33571401-6BDC01AC-5E39-4C6F-AB10-586E1F1855D1Q33960627-27410975-B94F-44CD-AE6D-1541646D8A00Q34362447-2B4A4DBB-7B71-4783-8BDD-37F135C1DCD8Q34587450-6BDF490C-F929-47A3-B396-A26A3DA38EA5Q34622399-9BBDF136-D598-4CFA-8D04-9FEE1E23D2E5Q34783696-47062EF8-09D9-49B7-82B1-B514B57C3125Q35010834-BC8974F2-2F3E-4F96-8407-A7375F47E123Q35127800-A7F62EF2-884A-465F-BC6D-8581F38B559CQ35404619-811ED67F-5467-437F-93BD-F66A3478EC49Q35604689-31B75230-BEC0-42D1-A848-2DCED42F0E00Q35622439-A01F3D8E-FA31-440E-BC6E-267BAED820CFQ35712872-781ADBDD-E010-4AC0-AA20-B9AFCFE49F03Q35750265-73958526-5496-4FDB-A082-BD7D2CF816DEQ36239060-F11620F8-4B09-494D-BB13-1ED68607034DQ36437749-56175912-064F-407C-BAFA-08EE51F89EBAQ36792219-B9CDDE66-F495-4BE6-8A67-8478492F0DA8Q36916081-FF3EA78D-6C55-45CA-9D82-E6EC92380E94Q37247584-153F9942-9DCB-41D8-8B46-0E191153FBD5Q37360860-F2F633DC-01BD-4E0A-B3C2-D82DA5FDAA23Q37453326-CD220399-A444-4C1E-ADB4-C5EC68E8B0D7Q38695114-E3AEFC9C-1847-44BA-98BA-C6DCD7E2AC46Q38751910-244C8E29-155D-4D06-9900-87C932B04214Q39376296-9F833ECA-1A8D-45EA-964E-D3E8C5D65EF9Q39451165-583B2704-B0A0-4A28-BEDF-8ECAE898F490Q39658873-AF25569B-5AB0-4C8E-9DDD-F2ED49E7E39AQ40065937-5B67C06E-D264-4D4C-9466-944B9D4F0503Q40199060-4EC35768-442F-4597-8361-6DBE21881969Q40392964-2322A4A3-5B2D-4219-870D-EF607F9A15D4Q40493675-227E3555-D3DB-45F7-B3CF-7A98A87A94A8Q40495171-E8C2C042-597B-472A-9546-2AD96CCB31B9Q40930960-44BBB8CE-80ED-46E7-991E-6B50F7562BB7Q42608658-DE47570D-736C-4200-B19B-2318265A5036Q42682745-ED86743C-7BC9-4E8F-AD96-CE28B1CCC7EFQ43044202-212BD534-BB23-48C7-A970-0512C1BBAEA5Q43425393-28064A15-2DD3-4368-B072-6F7B81FA0046Q43509434-2F4177B3-3EE3-4C44-9547-BFF3467A30AAQ43803237-9A6536F5-C7CB-4FF8-B876-F47D0ACAAE1AQ44361727-E0E5EDB6-0BCF-47DD-8C07-2FCA7EB8F1DA
P2860
Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacokinetic/pharmacodynami ...... s used in veterinary medicine.
@ast
Pharmacokinetic/pharmacodynami ...... s used in veterinary medicine.
@en
type
label
Pharmacokinetic/pharmacodynami ...... s used in veterinary medicine.
@ast
Pharmacokinetic/pharmacodynami ...... s used in veterinary medicine.
@en
prefLabel
Pharmacokinetic/pharmacodynami ...... s used in veterinary medicine.
@ast
Pharmacokinetic/pharmacodynami ...... s used in veterinary medicine.
@en
P2093
P2860
P1476
Pharmacokinetic/pharmacodynami ...... s used in veterinary medicine.
@en
P2093
McKellar QA
Sanchez Bruni SF
P2860
P304
P356
10.1111/J.1365-2885.2004.00603.X
P577
2004-12-01T00:00:00Z